Holen Sie sich die Stockscreener-App
25.42
4.33%
-1.15
Handel nachbörslich:
25.50
0.08
+0.31%
Schlusskurs vom Vortag:
$26.57
Offen:
$26.27
24-Stunden-Volumen:
1.44M
Relative Volume:
1.01
Marktkapitalisierung:
$1.95B
Einnahmen:
$1.29B
Nettoeinkommen (Verlust:
$67.69M
KGV:
33.01
EPS:
0.7701
Netto-Cashflow:
$184.42M
1W Leistung:
-18.97%
1M Leistung:
-17.06%
6M Leistung:
+21.16%
1J Leistung:
+16.71%
1-Tages-Spanne:
$25.39
$26.31
1-Wochen-Bereich:
$25.09
$31.43
52-Wochen-Spanne:
$16.10
$33.06
Progyny Inc Stock (PGNY) Company Profile
Firmenname
Progyny Inc
Sektor
Branche
Telefon
212-888-3124
Adresse
1359 BROADWAY, NEW YORK, NY
Compare PGNY vs UNH, CVS, ELV, CI, HUM
| Aktien | Preis | Marktkapitalisierung | Umsatz | Nettogewinn | Free Cashflow | ENV |
|---|---|---|---|---|---|---|
PGNY
Progyny Inc
|
25.42 | 2.04B | 1.29B | 67.69M | 184.42M | 0.7701 |
UNH
Unitedhealth Group Inc
|
405.59 | 361.00B | 450.13B | 14.91B | 23.62B | 15.55 |
CVS
Cvs Health Corp
|
94.72 | 119.58B | 407.94B | 2.90B | 7.39B | 2.2771 |
ELV
Elevance Health Inc
|
399.14 | 84.66B | 201.11B | 4.95B | 6.29B | 22.50 |
CI
Cigna Group
|
277.41 | 72.37B | 278.13B | 6.74B | 7.66B | 23.60 |
HUM
Humana Inc
|
388.83 | 44.77B | 137.20B | 1.15B | 1.27B | 9.3439 |
Progyny Inc Stock (PGNY) Upgrades & Downgrades
| Datum | Aktion | Analytiker | Ratingänderung |
|---|---|---|---|
| 2026-01-20 | Hochstufung | Citizens JMP | Mkt Perform → Mkt Outperform |
| 2026-01-08 | Hochstufung | Truist | Hold → Buy |
| 2025-12-09 | Eingeleitet | Barclays | Overweight |
| 2025-11-12 | Hochstufung | KeyBanc Capital Markets | Sector Weight → Overweight |
| 2025-07-08 | Hochstufung | Leerink Partners | Market Perform → Outperform |
| 2024-12-02 | Herabstufung | JP Morgan | Overweight → Neutral |
| 2024-11-13 | Herabstufung | Truist | Buy → Hold |
| 2024-09-19 | Herabstufung | JMP Securities | Mkt Outperform → Mkt Perform |
| 2024-08-07 | Herabstufung | BTIG Research | Buy → Neutral |
| 2024-08-07 | Herabstufung | Canaccord Genuity | Buy → Hold |
| 2024-08-07 | Herabstufung | Leerink Partners | Outperform → Market Perform |
| 2024-07-16 | Eingeleitet | JMP Securities | Mkt Outperform |
| 2024-05-10 | Herabstufung | KeyBanc Capital Markets | Overweight → Sector Weight |
| 2024-02-26 | Eingeleitet | Leerink Partners | Outperform |
| 2024-01-03 | Eingeleitet | Barclays | Overweight |
| 2023-09-27 | Eingeleitet | Canaccord Genuity | Buy |
| 2023-05-22 | Eingeleitet | BTIG Research | Buy |
| 2023-04-21 | Eingeleitet | Cantor Fitzgerald | Overweight |
| 2023-01-05 | Herabstufung | SVB Leerink | Outperform → Mkt Perform |
| 2022-09-16 | Eingeleitet | KeyBanc Capital Markets | Overweight |
| 2022-09-07 | Eingeleitet | Truist | Buy |
| 2021-12-02 | Eingeleitet | Jefferies | Buy |
| 2021-11-22 | Herabstufung | Citigroup | Buy → Neutral |
| 2021-09-30 | Eingeleitet | Berenberg | Buy |
| 2021-08-12 | Eingeleitet | Barclays | Overweight |
| 2021-06-02 | Herabstufung | Guggenheim | Buy → Neutral |
| 2021-04-29 | Fortgesetzt | JP Morgan | Overweight |
| 2021-03-10 | Hochstufung | BofA Securities | Neutral → Buy |
| 2020-07-01 | Eingeleitet | SVB Leerink | Outperform |
| 2020-06-02 | Eingeleitet | Guggenheim | Buy |
| 2019-11-19 | Eingeleitet | Citigroup | Buy |
| 2019-11-19 | Eingeleitet | Goldman | Buy |
| 2019-11-19 | Eingeleitet | JP Morgan | Overweight |
| 2019-11-19 | Eingeleitet | Piper Jaffray | Overweight |
| 2019-11-19 | Eingeleitet | SVB Leerink | Outperform |
Alle ansehen
Progyny Inc Aktie (PGNY) Neueste Nachrichten
PGNY Maintains Rating by Barclays -- Price Target Lowered to $30 - GuruFocus
Sei Investments Co. Decreases Stake in Progyny, Inc. $PGNY - marketbeat.com
Progyny Inc (PGNY) Stock Down 4.6% -- Now Undervalued? GF Score: 93/100 - GuruFocus
Progyny Drops 5.4% Amid Sector-Wide Selling - AlphaStreet
Progyny, Inc. $PGNY Shares Sold by Janus Henderson Group PLC - marketbeat.com
Why Progyny (PGNY) Shares Are Sliding Today - Yahoo Finance UK
Progyny (PGNY) Stock May Still Trade At A Discount As Earnings Hold Up - Yahoo Finance
Quantinno Capital Management LP Grows Position in Progyny, Inc. $PGNY - MarketBeat
PGNY Q2 CY2026 Deep Dive: Seasonality and Guidance Weigh on Positive Underlying Performance - Yahoo Finance
A Quick Look at Today's Ratings for Progyny(PGNY.US), With a Forecast Between $31 to $35 - Moomoo
PGNY SWOT Analysis: Strong Growth Potential Revealed in 10-Q Fil - GuruFocus
Progyny Inc (PGNY) Stock News Today - TradingKey
Progyny Posts Record Q2 Results, Expands Client Base - The Globe and Mail
CCORF Maintains Progyny(PGNY.US) With Buy Rating, Cuts Target Price to $35 - Moomoo
Progyny, Inc. Releases Q2 2026 Form 10-Q Filing Highlighting Financials and Risks - Kalkine Media
Why Progyny Stock Plunged, Then Gradually Recovered Today - AOL.com
Progyny CEO to present at Canaccord Genuity Ann... - Pluang
Progyny (NASDAQ:PGNY) Shares Gap DownHere's What Happened - marketbeat.com
Progyny, Inc. to Present at the Canaccord Genuity Annual Growth Conference - GlobeNewswire
Progyny CEO’s Aug. 11 Boston session will have a live audiocast - Stock Titan
Progyny, Inc. 2026: Revenue $350.51M, EPS $0.34— 10-Q Summary - TradingView
Progyny, Inc. Q2 2026 Earnings Call Summary - Yahoo Finance
Progyny, Inc. Stock 12‑Month Price Target Cut to $33.82, Implies 12% Upside - TradingView
Progyny Q2 2026 Earnings Call Transcript - marketbeat.com
Progyny, Inc. 2026 Q2ResultsEarnings Call Presentation (NASDAQ:PGNY) 2026-08-07 - Seeking Alpha
Progyny Outlook FY Adjusted Ebitda USD 233-24 - Moomoo
Progyny Inc (PGNY) (Q2 2026) Earnings Call Highlights: Record Re - GuruFocus
106,654 Shares in Progyny, Inc. $PGNY Bought by Empowered Funds LLC - marketbeat.com
Is Progyny Inc (PGNY) Fairly Valued After Q2 Earnings? EPS Matches Estimate at $0.34 with Revenue of $350.5 Million - GuruFocus
Progyny Q2 Earnings Call Highlights - marketbeat.com
Progyny Q2 2026 earnings: Margin expansion lifts profit faster than revenue - TradingKey
Progyny (PGNY) Reports Q2 Earnings: What Key Metrics Have to Say - Yahoo Finance
Progyny (NASDAQ:PGNY) Issues FY 2026 Earnings Guidance - marketbeat.com
Progyny (NASDAQ:PGNY) Issues Q3 2026 Earnings Guidance - marketbeat.com
Earnings call transcript: Progyny beats Q2 2026 estimates, shares sink after hours - Investing.com
Progyny (PGNY) Q2 Earnings and Revenues Beat Estimates - Yahoo Finance
Progyny, Inc. reports results for the quarter ended June 30Earnings Summary - TradingView
PROGYNY ($PGNY) Releases Q2 2026 Earnings - Quiver Quantitative
Q2 2026 Progyny Inc Earnings Call Transcript - GuruFocus
Progyny: Q2 Earnings Snapshot - Barchart.com
Progyny Q2 revenue rises 5%, slightly beats estimates - TradingView
Progyny’s (NASDAQ:PGNY) Q2 CY2026: Beats On Revenue But Stock Drops 10.2% - Yahoo Finance
Progyny, Inc. Announces Second Quarter 2026 Results - The Manila Times
Progyny: Member Engagement Typically Lessens During the Peak of the Summer Mos >PGNY - Moomoo
Tranche Update on Progyny, Inc.'s Equity Buyback Plan announced on May 26, 2026. - marketscreener.com
Earnings Flash (PGNY) Progyny, Inc. Reports Q2 Revenue $350.5M, vs. FactSet Est of $348.6M - marketscreener.com
(PGNY) Progyny, Inc. Expects Q3 Revenue Range $335.0M$345.0M - marketscreener.com
(PGNY) Progyny, Inc. Expects Q3 Adjusted EPS Range $0.50$0.52 - marketscreener.com
PROGYNY Q2 NET INCOME USD 28.052 MILLION - Moomoo
Progyny, Inc. Reports Earnings Results for the Second Quarter and Six Months Ended June 30, 2026 - marketscreener.com
Progyny earnings in focus as utilization trends face scrutiny By Investing.com - Investing.com Nigeria
Finanzdaten der Progyny Inc-Aktie (PGNY)
Umsatz
Nettogewinn
Free Cashflow
ENV
2.42%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):